delpacibart braxlosiran

News

Novartis' $12bn takeover of Avidity could potentially give it the first therapy for genetic disorder facioscapulohumeral muscular dystrophy.

News

The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.